Trailing-twelve-month (TTM) revenue is $333.62 Million with a year-over-year growth of +11.24%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $70,289,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2026-01-03 | $86,476,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-03 |
| Q1 FY2026Period ended 2026-04-04 | $83,038,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-07-04 | $93,816,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $333,619,000 |
Current P/S: $295,166,520 market capitalization ÷ $333,619,000 TTM revenue = 0.88x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:10:11.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $93.82M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:14:47.848Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Engineering | N/A | N/A | N/A | $85M | N/A | N/A |
| Engineering Services | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| CANADA | $15M | $10M | $5M | $6M | $7M | $8M |
| Europe | N/A | N/A | N/A |
$333.62M
$333.62 Million
+11.24%
vs. $299.91M a year ago (TTM)
+14.95%
5 Year compound annual growth rate
1 Year
+11.24%
3 Year
+8.29%
5 Year
+14.95%
10 Year
+6.07%
15 Year
+5.51%
20 Year
+2.96%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $319.40M | +$41.02M | +14.74% |
| 2024 | $278.38M | +$15.14M | +5.75% |
| 2023 | $263.24M | ($21.44M) | (7.53%) |
| 2022 | $284.68M | +$80.81M | +39.63% |
| 2021 | $203.88M | +$53.47M | +35.55% |
| 2020 |
TTM Growth
+11.24%
3-Year CAGR
+8.29%
5-Year CAGR
+14.95%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:14:47.848Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $96M |
| $120M |
| Health Care | N/A | N/A | N/A | N/A | $143M | $164M |
|---|
| Service, Other | $2M | $2M | $2M | N/A | N/A | N/A |
|---|
| Specialty Health Care | N/A | N/A | N/A | $136M | N/A | N/A |
|---|
| Technology Service | N/A | N/A | N/A | N/A | $39M | $35M |
|---|
| $7M |
| $15M |
| PUERTO RICO | $6M | $5M | $5M | $7M | $7M | $6M |
|---|
| SERBIA | $3M | $3M | $3M | N/A | N/A | N/A |
|---|
| UNITED STATES | $126M | $186M | $272M | $247M | $257M | $290M |
|---|
| $150.41M |
| ($40.69M) |
| (21.29%) |
| 2019 | $191.10M | ($9.25M) | (4.62%) |
| 2018 | $200.35M | +$13.62M | +7.29% |
| 2017 | $186.74M | +$10.29M | +5.83% |
| 2016 | $176.45M | ($9.29M) | (5.00%) |
